Amedisys Inc (AMED)
Quick ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 303,242 | 126,450 | 40,540 | 42,694 | 81,808 |
Short-term investments | US$ in thousands | — | 0 | — | — | — |
Receivables | US$ in thousands | — | — | — | — | — |
Total current liabilities | US$ in thousands | 514,392 | 473,721 | 355,529 | 374,282 | 456,337 |
Quick ratio | 0.59 | 0.27 | 0.11 | 0.11 | 0.18 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($303,242K
+ $—K
+ $—K)
÷ $514,392K
= 0.59
The quick ratio of Amedisys Inc, a key liquidity measure, reveals the company's ability to meet its short-term obligations with its most liquid assets. The trend analysis of the quick ratio from December 31, 2020, to December 31, 2024, indicates fluctuating levels.
Initially, on December 31, 2020, the quick ratio stood at 0.18, implying a relatively low ability to cover immediate liabilities with liquid assets. Subsequently, the ratio decreased to 0.11 by both December 31, 2021, and December 31, 2022, indicating a further deterioration in short-term liquidity.
A notable improvement was observed by December 31, 2023, with the quick ratio increasing to 0.27, suggesting a strengthened ability to meet short-term obligations with liquid assets. The most significant improvement was recorded by December 31, 2024, as the quick ratio surged to 0.59, signifying a substantial enhancement in liquidity position.
Overall, the fluctuation in Amedisys Inc's quick ratio over the years demonstrates varying levels of short-term liquidity management, with a notable positive trend observed towards the end of the period, indicating an improved ability to cover immediate obligations with liquid assets.
Peer comparison
Dec 31, 2024